Maryland grandfather sounds alarm on potential vision loss risk posed by weight-loss medication
Todd Engel, 63, was first prescribed Ozempic in 2023 to help manage his diabetes. Approximately four months later, he was diagnosed with NAION (nonarteritic anterior ischemic optic neuropathy).
